Polymorphisms in the IL-1β gene increase the risk of colon cancer development [181], while single-nucleotide polymorphisms (SNPs) associated with a high expression of IL-1Ra lead to better survival in patients with advanced CRC [182]. This evidence concerns the gene IL1B and colorectal carcinoma.